Clinical Trial Update: Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer. [Phase 2]

View source ↗

Summary

A Phase II trial evaluating intensity-modulated radiotherapy with a simultaneous integrated boost (IMRT-SIB) as adjuvant therapy for high-risk resected well-dif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Well-differentiated Thyroid Cancer

Snippet

Sponsor: Alberta Health services | Conditions: Thyroid Neoplasms | Phase 2 | Status: COMPLETED